Molecular strategies to inhibit the replication of RNA viruses.
about
Molecular targets for flavivirus drug discoveryInhibition of Chikungunya Virus Replication by 1-[(2-Methylbenzimidazol-1-yl) Methyl]-2-Oxo-Indolin-3-ylidene] Amino] Thiourea(MBZM-N-IBT)Current and future antiviral therapy of severe seasonal and avian influenzaReporter-Expressing, Replicating-Competent Recombinant ArenavirusesInhibition of RNA Recruitment and Replication of an RNA Virus by Acridine Derivatives with Known Anti-Prion ActivitiesPotential benefits of sequential inhibitor-mutagen treatments of RNA virus infectionsGene expression signature-based screening identifies new broadly effective influenza a antiviralsInhibition of pyrimidine biosynthesis pathway suppresses viral growth through innate immunityTargeting of arenavirus RNA synthesis by a carboxamide-derivatized aromatic disulfide with virucidal activityPeramivir: an intravenous neuraminidase inhibitor for the treatment of 2009 H1N1 influenza.Identification of influenza endonuclease inhibitors using a novel fluorescence polarization assay.Hemorrhagic fever of bunyavirus etiology: disease models and progress towards new therapies.Development of a new tacaribe arenavirus infection model and its use to explore antiviral activity of a novel aristeromycin analog.Highly sulfated K5 Escherichia coli polysaccharide derivatives inhibit respiratory syncytial virus infectivity in cell lines and human tracheal-bronchial histocultures.High-throughput screening for broad-spectrum chemical inhibitors of RNA viruses.Novel dengue virus-specific NS2B/NS3 protease inhibitor, BP2109, discovered by a high-throughput screening assay.Inhibition of chikungunya virus replication by harringtonine, a novel antiviral that suppresses viral protein expressionReverse genetics approaches to combat pathogenic arenavirusesGenetic diversity of a Korean echovirus 5 isolate and response of the strain to five antiviral drugs.Maporal virus as a surrogate for pathogenic New World hantaviruses and its inhibition by favipiravir.Emerging paramyxoviruses: molecular mechanisms and antiviral strategiesMolecular characterization and antiviral activity test of common drugs against echovirus 18 isolated in Korea.Evaluation of Adamantane Derivatives as Inhibitors of Dengue Virus mRNA Cap Methyltransferase by Docking and Molecular Dynamics Simulations.A genetic screen identifies interferon-α effector genes required to suppress hepatitis C virus replicationFlavivirus methyltransferase: a novel antiviral targetReverse Genetics Approaches to Control Arenavirus.Favipiravir (T-705) protects against peracute Rift Valley fever virus infection and reduces delayed-onset neurologic disease observed with ribavirin treatment.Influenza pharmacotherapy: present situation, strategies and hopes.Lymphocytic choriomeningitis virus (LCMV) infection of macaques: a model for Lassa fever.Host cell factors as antiviral targets in arenavirus infection.Influenza a virus entry: implications in virulence and future therapeutics.Development of Small-Molecule Antivirals for Ebola.Network pharmacology study on the mechanism of traditional Chinese medicine for upper respiratory tract infection.Trypsin promotes efficient influenza vaccine production in MDCK cells by interfering with the antiviral host response.Ribavirin can be mutagenic for arenaviruses.Respiratory syncytial virus-neutralizing monoclonal antibodies motavizumab and palivizumab inhibit fusionAntiviral screening identifies adenosine analogs targeting the endogenous dsRNA Leishmania RNA virus 1 (LRV1) pathogenicity factor.Plaque assay for human coronavirus NL63 using human colon carcinoma cells.Therapeutic Approaches for Zika Virus Infection of the Nervous System.RAGE inhibits human respiratory syncytial virus syncytium formation by interfering with F-protein function
P2860
Q21999123-103CB541-9BF7-41F9-83E2-2B038AD6D632Q24289284-20FDEE8F-1D15-485F-93D9-A4EB3F14EEE7Q24656164-9A70744E-47D9-45ED-8F09-F88897ABCA1DQ26742028-F77CA517-F6DE-4CBB-9881-548C494CD76FQ27489873-CA976C63-BFC7-4CF5-8FD1-DF71EAFC2C5FQ28471847-255F91CC-1939-4104-A3B2-E3899A5A905CQ28475681-67C4C2C8-BC2C-446F-BB51-210D35147270Q28534057-040DE1B8-C7BE-4839-B0EE-A78804A86A55Q28535297-93CC0D2B-1BBD-4B24-B465-C0AF8D9A2DBCQ30389887-E1DF6F7D-DC6E-498D-8888-590ADE49BC04Q30574395-80918309-115A-451B-BADD-73E6DF7D6BF9Q33439713-0C41966B-79DF-491E-84D2-56ED78374831Q33700461-35A01E89-9D98-48E8-B971-A3484905F839Q34057989-8E4C4A90-6792-4ED9-906D-22270CF4D0A7Q34230693-492221CF-D93F-4631-8349-EB6C2764B9FCQ34483487-81F6A2A5-DDD5-4730-92F9-F116D387AF32Q34527618-0ECE0F5F-9E31-4312-8656-E1A4461B81BBQ34596958-3FAD8325-7566-4B9A-9ED4-DF69E914925FQ34677656-2E4BC855-32D3-4023-A1A0-6507538B9A61Q35624775-0E7B9430-C59A-47BF-A517-5357BFC5A818Q35658152-A552E21B-2669-4EA1-B271-9C01066F3B8CQ36041320-AE6FEE19-3731-418B-B5A0-E204AB561E61Q36092127-63357ECC-63EE-48C2-B4EE-8681DC6C13FDQ36881106-D51E8261-5F90-424E-8E6A-F889E375CFC8Q37197519-32F567E6-855C-45D1-AE1E-FE8C58ACB777Q37543755-7BDFD219-5574-49F6-8BB7-672E289D47C7Q37683496-833D768F-09CD-43B8-9359-1D8AC1F217C1Q37857854-9EFDBCDC-B737-4064-94D3-D2B3B316FDA5Q37912497-400EDDC2-2B8C-4127-8114-FE5FAF045D1CQ38061425-B56157C7-674C-4111-88D3-5C85A4120CBDQ38077952-FB138BB2-03B3-4DD9-BF96-A6FA93152F92Q38546746-E6F24E6D-E146-4F87-A713-435CC15DF99FQ38977512-1E2F3BAE-F75D-4E10-9AFF-B9A6A9F94182Q39474200-60037665-4BDB-4C25-88D7-AC4306E5DF7AQ39544616-E87EA77B-A42F-40D4-8895-074D66A4BF87Q39697277-81F3CAFE-0DB8-4EB1-B34E-43DF696FCFF6Q40368500-8D7D8B0C-8035-4820-9256-70412F978069Q41829011-C0136667-5CDD-4B35-98F6-79C6C594826AQ41918254-16A706EC-64F0-4850-873B-E6E770429757Q42248771-0909BD04-B151-4D83-BE04-8E5A890DC2B0
P2860
Molecular strategies to inhibit the replication of RNA viruses.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 04 February 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Molecular strategies to inhibit the replication of RNA viruses.
@en
Molecular strategies to inhibit the replication of RNA viruses.
@nl
type
label
Molecular strategies to inhibit the replication of RNA viruses.
@en
Molecular strategies to inhibit the replication of RNA viruses.
@nl
prefLabel
Molecular strategies to inhibit the replication of RNA viruses.
@en
Molecular strategies to inhibit the replication of RNA viruses.
@nl
P50
P1433
P1476
Molecular strategies to inhibit the replication of RNA viruses.
@en
P356
10.1016/J.ANTIVIRAL.2008.01.004
P577
2008-02-04T00:00:00Z